Progress in Medicinal Chemistry: Progress in Medicinal Chemistry, cartea 52
G. Lawton, David R. Wittyen Limba Engleză Hardback – mar 2013
- Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry
- This volume continues in the serial's tradition of providing an insight into the skills required of the modern medicinal chemist; in particular, the use of an appropriate selection of the wide range of tools now available to solve key scientific problems
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Hardback (5) | 830.58 lei 5-7 săpt. | |
| ELSEVIER SCIENCE – feb 2016 | 830.58 lei 5-7 săpt. | |
| ELSEVIER SCIENCE – 10 feb 2015 | 831.63 lei 5-7 săpt. | |
| ELSEVIER SCIENCE – mar 2013 | 987.06 lei 6-8 săpt. | |
| ELSEVIER SCIENCE – 6 oct 2010 | 1282.05 lei 6-8 săpt. | |
| ELSEVIER SCIENCE – 3 mar 2011 | 1282.75 lei 6-8 săpt. |
Preț: 987.06 lei
Preț vechi: 1352.14 lei
-27%
Puncte Express: 1481
Preț estimativ în valută:
174.75€ • 203.48$ • 151.80£
174.75€ • 203.48$ • 151.80£
Carte tipărită la comandă
Livrare economică 24 februarie-10 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780444626523
ISBN-10: 0444626522
Pagini: 264
Dimensiuni: 152 x 229 x 16 mm
Greutate: 0.51 kg
Ediția:New.
Editura: ELSEVIER SCIENCE
Seria Progress in Medicinal Chemistry
ISBN-10: 0444626522
Pagini: 264
Dimensiuni: 152 x 229 x 16 mm
Greutate: 0.51 kg
Ediția:New.
Editura: ELSEVIER SCIENCE
Seria Progress in Medicinal Chemistry
Public țintă
Chemists, biologists, doctors, pharmacists and anyone interested in the contemporary controversy about drugs, drug firms, and the communityCuprins
- Property-Based Design in the Optimisation of Benzamide Glucokinase Activators: From Hit to ClinicDarren McKerrecher and Michael J. Waring
- Medicinal Chemistry of Glucagon-like Peptide Receptor AgonistsLyn H. Jones and David A. Price
- Antimalarial Drug Discovery: Recent Progress and Future DirectionsFelix Calderón, David M. Wilson and Francisco-Javier Gamo
- Advances in the Discovery of Selective JAK Inhibitors
Christel J. Menet, Luc Van Rompaey and Raphael Geney